KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 11,100
-500 (-4.31%)
At close: Mar 31, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 126.74 billion as of April 1, 2026. Its market cap has decreased by -27.01% in one year.
Market Cap
126.74B
Enterprise Value
138.14B
Revenue
87.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,100.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 126.74B, a decrease of -31.04%. That is a compound annual growth rate of -6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 126.74B | -10.62% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 156.74B |
| Kyung Dong Pharmaceutical | 148.45B |
| DongKoo Bio & Pharma | 147.11B |
| PHARMARESEARCH BIO | 132.53B |
| Pharos iBio | 129.46B |
| HYUNDAI BIOLAND | 125.70B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 111.43B |
| Daehan Nupharm | 101.90B |